Heroin Dependence clinical trials
The registry lists 87 studies for Heroin Dependence across more than 10 countries. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2025-10-27.
Status
- Completed
- 62
- Status unknown
- 15
- Withdrawn
- 7
- Terminated
- 3
Phase
- Phase 2
- 27
- Phase 3
- 18
- Phase 1
- 9
- Phase 4
- 7
Where
- United States
- 60
- China
- 5
- Taiwan
- 4
- Malaysia
- 3
- Sweden
- 3
- Russian Federation
- 2
Who runs them
National Institute on Drug Abuse (NIDA) (14) · New York State Psychiatric Institute (10) · Wayne State University (7) · University of Colorado, Denver (6) · Johns Hopkins University (6) · National Health Research Institutes, Taiwan (4) · Universiti Sains Malaysia (3) · Yale University (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 87 — search for more.
- Neuroimaging and CBD for Opioid Use DisorderCompletedNCT04567784Phase 21 country
- Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use DisorderTerminatedNCT04495673Not applicable1 country
- Biomarkers of Injectable Extended Release Naltrexone TreatmentCompletedNCT02324725Phase 41 country
- Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent IndividualsTerminatedNCT03711318Phase 31 country
- Repetitive Transcranial Magnetic Stimulation to Reduce Heroin CravingsCompletedNCT05074524Not applicable1 country
- The Effect of Self-Forgiveness on Self-Stigma in Addiction.CompletedNCT03971097Not applicable1 country
- Aprepitant Effects in Intravenous Heroin DependenceCompletedNCT01527994Phase 11 country
- Extended-Release Naltrexone Opioid Treatment at Jail Re-EntryCompletedNCT01999946Phase 41 country
- Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin DependenceStatus unknownNCT03922659Not applicable1 country
- PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin AddictionStatus unknownNCT04086459Not applicable1 country
- Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid AbstinenceCompletedNCT03015246Phase 1/21 country
- Repetitive Transcranial Magnetic Stimulation in Patients With Opioid Use DisordersStatus unknownNCT03229642Not applicable1 country
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1CompletedNCT00023283Phase 21 country
- Study of Computer-Based Treatment for Drug DependenceCompletedNCT01315184Phase 21 country
- Laser Meridian Massage in Heroin AddictsStatus unknownNCT04003077Not applicable1 country
- Methadone Induced Memory Retrieval-extinction Procedure in Heroin AddictsCompletedNCT04133974Not applicable
- Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical TrialCompletedNCT00684554Phase 2/31 country
- Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary CareCompletedNCT004710421 country
- Addiction Treatment in Russia: Oral vs. Naltrexone ImplantCompletedNCT00218426Phase 2/32 countries
- Buprenorphine for PrisonersCompletedNCT00574067Phase 31 country
- University of Houston Drug Abuse Research Development Program IIStatus unknownNCT03557632Not applicable1 country
- Memantine as a Supplement to Naltrexone in Treating Heroin DependenceCompletedNCT00476242Phase 2/31 country
- Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone EffectsCompletedNCT015369251 country
- Effect of Clonidine on Responses to Imagery ScriptsCompletedNCT00318760Phase 11 country
- Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1CompletedNCT00218634Not applicable1 country
- The Therapeutic Workplace Initiation StudyCompletedNCT00249470Not applicable1 country
- Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2CompletedNCT00249457Not applicable1 country
- Employment-based Reinforcement of Naltrexone Ingestion and AbstinenceCompletedNCT00149669Not applicable1 country
- Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/NaloxoneCompletedNCT01760473Phase 31 country
- Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot NaltrexoneCompletedNCT00577408Phase 31 country
- Pioglitazone for Heroin and for Nicotine DependenceTerminatedNCT01395797Phase 1/21 country
- A Laboratory Model for Heroin Abuse Medications - 8CompletedNCT00000273Phase 21 country
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4WithdrawnNCT00000329Phase 21 country
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3WithdrawnNCT00000328Phase 21 country
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2WithdrawnNCT00000327Phase 21 country
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5WithdrawnNCT00000330Phase 21 country
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1WithdrawnNCT00000326Phase 21 country
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6WithdrawnNCT00000331Phase 21 country
- Economic Evaluation Comparing CCT With MMT in Hai Phong City, VietnamCompletedNCT030713151 country
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 31 country
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNCT00249574Not applicable1 country
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 41 country
- Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1CompletedNCT00032955Phase 31 country
- Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1CompletedNCT00218530Phase 11 country
- Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing RegimensCompletedNCT00218127Phase 21 country
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 2CompletedNCT00000211Phase 21 country
- Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent IndividualsCompletedNCT002183091 country
- The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1CompletedNCT00158288Phase 21 country
- Buprenorphine and Naloxone Combination Study - 10CompletedNCT00015288Phase 11 country
- Addition of Naltrexone to Methadone TaperCompletedNCT00135759Phase 21 country